$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 70.97 | 1,538 | 109,154 | 32,751 | 34.3 K to 32.8 K (-4.49 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 1,285 | 34,695 | 23,138 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 1,285 | 34,695 | 23,138 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 937 | 29,159 | 29,835 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 937 | 29,159 | 29,835 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 1,285 | 34,695 | 19,985 | 18.7 K to 20 K (+6.87 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 1,285 | 34,695 | 19,985 | 18.7 K to 20 K (+6.87 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 937 | 29,159 | 18,700 | 17.8 K to 18.7 K (+5.28 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 937 | 29,159 | 18,700 | 17.8 K to 18.7 K (+5.28 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 42,521 | 3,018,995 | 9,302,929 | 9.3 M to 9.3 M (-0.45 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 6,529 | 463,560 | 1,462,748 | 1.5 M to 1.5 M (-0.44 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 1,125 | 79,875 | 285,848 | 287 K to 285.8 K (-0.39 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 652 | 46,292 | 182,885 | 183.5 K to 182.9 K (-0.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 50 | 3,550 | 51,550 | 51.6 K to 51.6 K (-0.10 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 729 | 51,759 | 199,451 | 200.2 K to 199.5 K (-0.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 10,547 | 755,298 | 9,345,450 | 9.4 M to 9.3 M (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 1,619 | 115,941 | 1,469,277 | 1.5 M to 1.5 M (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 279 | 19,980 | 286,973 | 287.3 K to 287 K (-0.10 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 162 | 11,601 | 183,537 | 183.7 K to 183.5 K (-0.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 12 | 859 | 51,600 | 51.6 K to 51.6 K (-0.02 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 181 | 12,962 | 200,180 | 200.4 K to 200.2 K (-0.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 13,595 | 981,964 | 9,355,997 | 9.4 M to 9.4 M (-0.15 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 2,087 | 150,744 | 1,470,896 | 1.5 M to 1.5 M (-0.14 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 360 | 26,003 | 287,252 | 287.6 K to 287.3 K (-0.13 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 209 | 15,096 | 183,699 | 183.9 K to 183.7 K (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 16 | 1,156 | 51,612 | 51.6 K to 51.6 K (-0.03 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 233 | 16,830 | 200,361 | 200.6 K to 200.4 K (-0.12 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 132,363 | 9,634,226 | 9,369,592 | 9.5 M to 9.4 M (-1.39 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 20,322 | 1,479,165 | 1,472,983 | 1.5 M to 1.5 M (-1.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 3,503 | 254,971 | 287,612 | 291.1 K to 287.6 K (-1.20 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 2,031 | 147,829 | 183,908 | 185.9 K to 183.9 K (-1.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 155 | 11,282 | 51,628 | 51.8 K to 51.6 K (-0.30 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 2,268 | 165,080 | 200,594 | 202.9 K to 200.6 K (-1.12 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 149,754 | 10,601,295 | 9,501,955 | 9.7 M to 9.5 M (-1.55 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 22,991 | 1,627,565 | 1,493,305 | 1.5 M to 1.5 M (-1.52 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 3,963 | 280,546 | 291,115 | 295.1 K to 291.1 K (-1.34 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 2,298 | 162,679 | 185,939 | 188.2 K to 185.9 K (-1.22 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 175 | 12,388 | 51,783 | 52 K to 51.8 K (-0.34 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 2,566 | 181,651 | 202,862 | 205.4 K to 202.9 K (-1.25 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 493 | 34,545 | 9,651,709 | 9.7 M to 9.7 M (-0.01 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 76 | 5,325 | 1,516,296 | 1.5 M to 1.5 M (-0.01 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 13 | 911 | 295,078 | 295.1 K to 295.1 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 8 | 561 | 188,237 | 188.2 K to 188.2 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 1 | 70 | 51,958 | 52 K to 52 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 9 | 631 | 205,428 | 205.4 K to 205.4 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 23,462 | 1,647,574 | 9,652,202 | 9.7 M to 9.7 M (-0.24 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 3,602 | 252,944 | 1,516,372 | 1.5 M to 1.5 M (-0.24 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 621 | 43,609 | 295,091 | 295.7 K to 295.1 K (-0.21 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 360 | 25,280 | 188,245 | 188.6 K to 188.2 K (-0.19 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 27 | 1,896 | 51,959 | 52 K to 52 K (-0.05 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 402 | 28,230 | 205,437 | 205.8 K to 205.4 K (-0.20 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 8,392 | 589,772 | 9,675,664 | 9.7 M to 9.7 M (-0.09 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 1,288 | 90,518 | 1,519,974 | 1.5 M to 1.5 M (-0.08 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 222 | 15,602 | 295,712 | 295.9 K to 295.7 K (-0.08 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 129 | 9,066 | 188,605 | 188.7 K to 188.6 K (-0.07 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 10 | 703 | 51,986 | 52 K to 52 K (-0.02 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 144 | 10,120 | 205,839 | 206 K to 205.8 K (-0.07 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 10,000 | 229,800 | 36,424 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 31,471 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 67.85 | 4,472 | 303,413 | 44,047 | 48.5 K to 44 K (-9.22 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 66.67 | 3,428 | 228,528 | 48,519 | 51.9 K to 48.5 K (-6.60 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 65.87 | 2,100 | 138,330 | 51,947 | 54 K to 51.9 K (-3.89 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 10,000 | 229,800 | 54,047 | 44 K to 54 K (+22.70 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 67.86 | 2,200 | 149,290 | 44,047 | 46.2 K to 44 K (-4.76 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 66.68 | 1,700 | 113,355 | 46,247 | 47.9 K to 46.2 K (-3.55 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 65.90 | 1,100 | 72,485 | 47,947 | 49 K to 47.9 K (-2.24 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 49,047 | 44 K to 49 K (+11.35 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 30,772 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 67.95 | 1,200 | 81,542 | 17,763 | 19 K to 17.8 K (-6.33 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 66.82 | 1,000 | 66,819 | 18,963 | 20 K to 19 K (-5.01 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 66.03 | 800 | 52,820 | 19,963 | 20.8 K to 20 K (-3.85 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,763 | 17.8 K to 20.8 K (+16.89 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 64.41 | 155 | 9,984 | 67,619 | 67.5 K to 67.6 K (+0.23 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 64.41 | 155 | 9,984 | 6,332 | 6.2 K to 6.3 K (+2.51 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 64.41 | 155 | 9,984 | 51,803 | 51.6 K to 51.8 K (+0.30 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 67.46 | 3,722 | 251,102 | 116,982 | 120.7 K to 117 K (-3.08 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 66.74 | 17,208 | 1,148,433 | 120,704 | 137.9 K to 120.7 K (-12.48 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 65.79 | 4,070 | 267,751 | 137,912 | 142 K to 137.9 K (-2.87 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 68.53 | 1,200 | 82,233 | 141,982 | 143.2 K to 142 K (-0.84 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 67.89 | 7,014 | 476,184 | 143,182 | 150.2 K to 143.2 K (-4.67 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 66.78 | 9,079 | 606,340 | 150,196 | 159.3 K to 150.2 K (-5.70 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 65.85 | 7,707 | 507,484 | 159,275 | 167 K to 159.3 K (-4.62 %) |
| Dec 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 589 | 0 | 57,068 | 57.7 K to 57.1 K (-1.02 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | M | 25.79 | 8,250 | 212,768 | 0 | |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | M | 14.37 | 8,250 | 118,553 | 0 | |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Buy | M | 25.79 | 8,250 | 212,768 | 51,648 | 43.4 K to 51.6 K (+19.01 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Buy | M | 14.37 | 8,250 | 118,553 | 43,398 | 35.1 K to 43.4 K (+23.47 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Buy | M | 17.59 | 8,250 | 145,118 | 35,148 | 26.9 K to 35.1 K (+30.67 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 10,000 | 229,800 | 46,424 | |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 36,471 | |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 74.42 | 800 | 59,538 | 44,047 | 44.8 K to 44 K (-1.78 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 73.10 | 600 | 43,857 | 44,847 | 45.4 K to 44.8 K (-1.32 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 71.53 | 2,200 | 157,368 | 45,447 | 47.6 K to 45.4 K (-4.62 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 70.61 | 1,400 | 98,848 | 47,647 | 49 K to 47.6 K (-2.85 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 74.61 | 1,300 | 96,992 | 49,047 | 50.3 K to 49 K (-2.58 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 73.56 | 900 | 66,201 | 50,347 | 51.2 K to 50.3 K (-1.76 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 72.73 | 700 | 50,910 | 51,247 | 51.9 K to 51.2 K (-1.35 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 71.54 | 4,571 | 326,997 | 51,947 | 56.5 K to 51.9 K (-8.09 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 70.58 | 2,529 | 178,508 | 56,518 | 59 K to 56.5 K (-4.28 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 59,047 | 54 K to 59 K (+9.25 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 10,000 | 229,800 | 54,047 | 44 K to 54 K (+22.70 %) |
| Dec 13 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Gift | G | 0.00 | 1,633 | 0 | 44,047 | 45.7 K to 44 K (-3.57 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 15,243 | 1,114,047 | 9,683,746 | 9.7 M to 9.7 M (-0.16 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 2,340 | 171,021 | 1,520,952 | 1.5 M to 1.5 M (-0.15 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 403 | 29,454 | 295,624 | 296 K to 295.6 K (-0.14 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 234 | 17,102 | 188,424 | 188.7 K to 188.4 K (-0.12 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 18 | 1,316 | 51,686 | 51.7 K to 51.7 K (-0.03 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.09 | 262 | 19,148 | 205,673 | 205.9 K to 205.7 K (-0.13 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 12,627 | 906,797 | 9,698,989 | 9.7 M to 9.7 M (-0.13 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 1,939 | 139,248 | 1,523,292 | 1.5 M to 1.5 M (-0.13 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 334 | 23,986 | 296,027 | 296.4 K to 296 K (-0.11 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 194 | 13,932 | 188,658 | 188.9 K to 188.7 K (-0.10 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 15 | 1,077 | 51,704 | 51.7 K to 51.7 K (-0.03 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.81 | 216 | 15,512 | 205,935 | 206.2 K to 205.9 K (-0.10 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 34,794 | 2,605,510 | 9,711,616 | 9.7 M to 9.7 M (-0.36 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 5,342 | 400,030 | 1,525,231 | 1.5 M to 1.5 M (-0.35 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 921 | 68,968 | 296,361 | 297.3 K to 296.4 K (-0.31 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 534 | 39,988 | 188,852 | 189.4 K to 188.9 K (-0.28 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 41 | 3,070 | 51,719 | 51.8 K to 51.7 K (-0.08 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.88 | 597 | 44,706 | 206,151 | 206.7 K to 206.2 K (-0.29 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 7,718 | 569,813 | 9,746,410 | 9.8 M to 9.7 M (-0.08 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 1,185 | 87,487 | 1,530,573 | 1.5 M to 1.5 M (-0.08 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 204 | 15,061 | 297,282 | 297.5 K to 297.3 K (-0.07 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 118 | 8,712 | 189,386 | 189.5 K to 189.4 K (-0.06 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 9 | 664 | 51,760 | 51.8 K to 51.8 K (-0.02 %) |
| Dec 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.83 | 132 | 9,745 | 206,748 | 206.9 K to 206.7 K (-0.06 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 84,418 | 6,428,768 | 9,754,128 | 9.8 M to 9.8 M (-0.86 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 12,961 | 987,032 | 1,531,758 | 1.5 M to 1.5 M (-0.84 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 2,234 | 170,128 | 297,486 | 299.7 K to 297.5 K (-0.75 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 1,296 | 98,696 | 189,504 | 190.8 K to 189.5 K (-0.68 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 99 | 7,539 | 51,769 | 51.9 K to 51.8 K (-0.19 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.15 | 1,447 | 110,195 | 206,880 | 208.3 K to 206.9 K (-0.69 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 76,364 | 5,762,481 | 9,838,546 | 9.9 M to 9.8 M (-0.77 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 11,724 | 884,701 | 1,544,719 | 1.6 M to 1.5 M (-0.75 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 2,021 | 152,506 | 299,720 | 301.7 K to 299.7 K (-0.67 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 1,172 | 88,440 | 190,800 | 192 K to 190.8 K (-0.61 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 89 | 6,716 | 51,868 | 52 K to 51.9 K (-0.17 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.46 | 1,309 | 98,778 | 208,327 | 209.6 K to 208.3 K (-0.62 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 2,538 | 197,318 | 9,914,910 | 9.9 M to 9.9 M (-0.03 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 390 | 30,321 | 1,556,443 | 1.6 M to 1.6 M (-0.03 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 67 | 5,209 | 301,741 | 301.8 K to 301.7 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 39 | 3,032 | 191,972 | 192 K to 192 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 3 | 233 | 51,957 | 52 K to 52 K (-0.01 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.75 | 43 | 3,343 | 209,636 | 209.7 K to 209.6 K (-0.02 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 5,493 | 405,449 | 9,917,448 | 9.9 M to 9.9 M (-0.06 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 843 | 62,223 | 1,556,833 | 1.6 M to 1.6 M (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 146 | 10,777 | 301,808 | 302 K to 301.8 K (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 84 | 6,200 | 192,011 | 192.1 K to 192 K (-0.04 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 6 | 443 | 51,960 | 52 K to 52 K (-0.01 %) |